| http://www.w3.org/ns/prov#value | - together with ketoconazole or other potent CYP3A4 inhibitor.16 Despite the recommendations from this earlier study, treatment guidelines have discouraged use of AL in HIV-coinfected patients requiring ARV treatment due to the concern that a clinically significant interaction between AL and ARVs may occur.12 Therefore, a definitive PK study, best achieved through enrollment of healthy volunteers, w
|
